Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Depreciation & Amortization (CF) (2024 - 2026)

Prelude Therapeutics' Depreciation & Amortization (CF) history spans 3 years, with the latest figure at $391000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 10.11% to $391000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.7 million, a 6.4% decrease, with the full-year FY2025 number at $1.7 million, down 3.44% from a year prior.
  • Depreciation & Amortization (CF) hit $391000.0 in Q1 2026 for Prelude Therapeutics, down from $418000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for PRLD hit a ceiling of $489000.0 in Q4 2024 and a floor of $391000.0 in Q1 2026.
  • Historically, Depreciation & Amortization (CF) has averaged $430444.4 across 3 years, with a median of $426000.0 in 2024.
  • The widest YoY moves for Depreciation & Amortization (CF): up 4.94% in 2025, down 14.52% in 2025.
  • Tracing PRLD's Depreciation & Amortization (CF) over 3 years: stood at $489000.0 in 2024, then dropped by 14.52% to $418000.0 in 2025, then fell by 6.46% to $391000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for PRLD at $391000.0 in Q1 2026, $418000.0 in Q4 2025, and $425000.0 in Q3 2025.